, and addition to its postsynaptic inhibitory properties, GABA Jean-Luc Gaïarsa. Ontogenesis of presynaptic GABA B receptor-also reduces neurotransmitter release through the activation mediated inhibition in the CA3 region of the rat hippocampus. of presynaptic GABA B receptors ( Bowery 1993; Deisz and J. Neurophysiol. 79: 1341-1348, 1998. g-Aminobutyric acid-B Prince 1989; Thompson and Gähwiler 1989a ) . Early in (GABA B ) receptor-dependent and -independent components of development, postsynaptic GABA A receptor mediated repaired-pulse depression (PPD) were investigated in the rat CA3 sponses can be elicited by stimulation of GABAergic afferhippocampal region. Intracellular and whole cell recordings of CA3 ent fibres or by exogenous application of GABA A receptor pyramidal neurons were performed on hippocampal slices obtained agonists Lo Turco et al. 1995 ) . Postfrom neonatal (5-7 day old) and adult (27-34 day old) rats.
ent fibres or by exogenous application of GABA A receptor pyramidal neurons were performed on hippocampal slices obtained agonists Lo Turco et al. 1995 ) . Postfrom neonatal (5-7 day old) and adult (27-34 day old) rats.
Electrical stimulation in the hilus evoked monosynaptic GABA A synaptic GABA B inhibition appears later in development postsynaptic currents (eIPSCs) isolated in the presence of the iono-and reaches adult levels by the end of the first postnatal tropic glutamate receptor antagonists 6-cyano-7-nitroquinoxaline-week of life in the visual cortex ( Luhmann and Prince 2,3-dione (CNQX, 10 mM) and D (0)2-amino-5-phosphovaleric 1991 ) and the hippocampus ; Janigro acid (D-AP5, 50 mM) with 2(triethylamino)-N-(2,6-dimethylphe-and Schwartzkroin 1988 ) . In contrast, presynaptic GABA B nyl) acetamine (QX314) filled electrodes. In adult CA3 pyramidal mediated inhibition is already functional at early stages neurons, when a pair of identical stimuli was applied at interstimuof development. Indeed, in the cortex, both synaptically lus intervals (ISIs) ranging from 50 to 1,500 ms the amplitude of released GABA ( Fukuda et al. 1993 ) and exogenously apthe second eIPSC was depressed when compared with the first plied GABA B receptor agonist, baclofen ( Harrison et al. eIPSC. This paired-pulse depression (PPD) was partially blocked by P-3-aminopropyl-P-diethoxymethyl phosphoric acid 1988 ) , depresses GABAergic transmission through a pre-(CGP35348, 0.5 mM), a selective GABA B receptor antagonist. In synaptic mechanism. In the neonatal hippocampus, presynneonates, PPD was restricted to ISIs shorter than 200 ms and was aptic GABA B receptors have a key role in the control of not affected by CGP35348. The GABA B receptor agonist baclofen endogenous polysynaptic network activity ( McLean et al. reduced the amplitude of eIPSCs in a dose-dependent manner with 1996 ) . The importance of this presynaptic inhibition is the same efficiency in both adults and neonates. Increasing the emphasised by the fact that before postnatal day 5 postsynprobability of transmitter release with high Ca 2/ (4 mM)/low aptic GABA A receptor-mediated activity is excitatory Mg 2/ (0.3 mM) external solution revealed PPD in neonatal CA3 Khazipov et al. 1997; pyramidal neurons that was 1) partially prevented by CGP35348,
2) independent of the membrane holding potential of the recorded al. 1997 ) , while postsynaptic GABA B inhibition is not yet cell, and 3) not resulting from a change in the reversal potential functional . Because baclofen reduces of GABA A eIPSCs. In adults the GABA uptake blocker tiagabine the amplitude of GABAergic inhibitory postsynaptic poten-(20 mM) increased the duration of eIPSCs and the magnitude tials , the question remains as to of GABA B receptor-dependent PPD. In neonates, tiagabine also whether or not presynaptic GABA B receptors are operaincreased duration of eIPSCs but to a lesser extent than in adult tional at the level of monosynaptic GABAergic transmisand did not reveal a GABA B receptor-dependent PPD. These results sion. In cerebellar organotypic slice cultures for example, demonstrate that although GABA B receptor-dependent and -indepaired-pulse depression is not observed while application pendent mechanisms of presynaptic inhibition are present on GABAergic terminals and functional, they do not operate at the of GABA B receptor agonists reduces both spontaneous and level of monosynaptic GABAergic synaptic transmission at early evoked GABAergic synaptic potentials ( Mouginot and Gäh-stages of development. Absence of presynaptic autoinhibition of wiler 1996 ) .
GABA release seems to be due to the small amount of transmitter
The aim of the present study was to investigate the presynthat can access presynaptic regulatory sites.
aptic inhibition of GABAergic synaptic transmission by endogenously released transmitter in the CA3 region of the neonatal rat hippocampus by using the paired-pulse protocol Davies et al. 1990 ). We report that while presynaptic GABA B receptor-dependent and -independent mechaIn the adult vertebrate CNS, g-aminobutyric acid nisms are present and functional on GABAergic terminals, ( GABA ) exerts postsynaptic inhibitory actions via at least they do not operate in the control of monosynaptic GABAertwo different classes of receptors, the GABA A receptor ungic currents under basal conditions: the emergence of derlying fast postsynaptic inhibitory transmission and the GABAergic presynaptic autoinhibition in neonates requires GABA B receptor, which mediates slow inhibitory postsynaptic potentials ( reviewed by Sivilotti and Nistri 1991 ) . In an increase in neurotransmitter release. FIG . 1. Absence of PPD in CA3 region of neonates. A: averaged (n Å 5) superimposed traces representing pairs of evoked inhibitory postsynaptic potential (eIPSCs) evoked at different interstimulus intervals (ISIs) (100, 200, 300, 500, 1,000 ms) from a holding potential of 060 mV in a P27 neuron. B: grouped adult data (mean { SE) representing % of PPD in control (n Å 14) and in presence of P-3-aminopropyl-P-diethoxymethyl phosphoric acid (CGP35348; 0.5 mM) (n Å 7) at different ISIs. CGP35348 significantly reversed paired-pulse depression (PPD) at 100, 200, and 300 ms. C: averaged (n Å 5) superimposed traces representing pairs of eIPSCs evoked at different ISIs (100, 200, 300, 500, 1,000 ms) from a holding potential of 060 mV in a P5 neuron. D: grouped neonate data (mean { SE) representing % of PPD in control (n Å 23 for ISIs 50-500; n Å 8 for ISI 1,000-1,500) and in presence of CGP35348 (0.5 mM) (n Å 6 for ISIs 50-500; n Å 3 for ISI 1,000-1,500) at different ISIs. CGP35348 did not significantly reverse PPD in range of ISIs studied.
age clamp mode with a sampling rate of 3-5 kHz, a time constant
of 20 ms, and a gain of 2.5-5.0 nA/mV. To ensure correct opera-
Preparation of hippocampal slices
tion of the clamp, the voltage at the head stage amplifier was monitored on a separate oscilloscope. Membrane potential was Brains were removed from neonate (5-7 day old) and adult estimated from the potential observed on withdrawal of the elec-(27-34 day old) male Wistar rats [postnatal day (P)5-P7 or P27-trode from the cell. 34] (P0 taken as the day of birth) under ether anesthesia and
To test the effect of baclofen on GABA A eIPSCs, whole cell submerged in cold artificial cerebrospinal fluid (ACSF) where the recordings were obtained by using the ''blind'' patch clamp techhippocampi were isolated. The composition of control ACSF was nique. Recordings were performed with an Axopatch 200A (Axon (in mM) 126 NaCl, 3.5 KCl, 2 CaCl 2 , 1.3 MgCl 2 , 1.2 NaH 2 PO 4 , Instruments) amplifier. Microelectrodes (7-10 MV) were filled 25 NaHCO 3 , and 11 glucose, pH 7.4, after equilibration with 95% with an internal solution of the following composition (in mM): O 2 -5% CO 2 . Hippocampal slices were cut at 600 mm thickness for 145 CsCl, 2 MgATP, 0.6 NaGTP, 1 ethylene glycol-bis (b-aminoneonates and 450 mM thickness for adults, with a McIlwain tissue ethyl ether)-N,N,N,N-tetraacetic acid (EGTA), 10 N-2-hychopper and incubated at room temperature in ACSF for at least droxyethylpiperazine-N-2-ethanesulfonic acid (HEPES), and 2 1 h before use. Individual slices were then transferred to a sub-QX314, pH i Å 7.25, osmolarity i Å 270 mosM. During experiments, merged-type recording chamber and superfused with ACSF at 2.8 before each stimulation, series resistances were determined by an ml/min at 34ЊC.
on-line fitting analysis of the transient currents during a 5 mV pulse with Acquis Software. Cells exhibiting unstable series resistances
Electrophysiological recordings
or resistances ú15 MV were discarded. Recordings were obtained from pyramidal neurons in the CA3b region of the hippocampus. All experiments investigating paired-Stimulation parameters pulse depression (PPD) of evoked inhibitory postsynaptic currents
Electrical stimulation was performed with a bipolar electrode (IPSCs) in control conditions, in high Ca 2/ /low Mg 2/ ACSF and constructed from twisted NiCr insulated wire (50 mm diam). The in the presence of tiagabine were performed with conventional stimulation electrode was positioned in the hilus. The parameters sharp microelectrodes (1.5 mm OD, Clark Electromedical) filled (20-40 ms, 20-60 V) were chosen to give maximal amplitude of with 50 mM 2(triethylamino)-N-(2,6-dimethylphenyl) acetamine the isolated eIPSC; paired-pulse stimulations were given at inter-(QX314) dissolved in 3 M KCl (resistance 30-55 MV). QX314, stimulus intervals (ISI) ranging from 50 to 1,500 ms at a frequency a derivative of lidocaine, used to block both voltage-dependent of 0.02 Hz. sodium channels (Flatman et al. 1982 ) and the GABA B receptor activated potassium conductance (Andrade et al. 1991; Perkins and Wong 1995) was injected by positive current pulses (0.3 nA, 300 Data acquisition, storage, and analysis ms, 0.5 Hz). Under these conditions electrical stimulation in the hilus induced only a GABA A -mediated potential without any slow Evoked synaptic potentials were stored on a personal computer and simultaneously displayed on a digital oscilloscope (Nicolet, GABA B component (see Fig. 1 The same protocol was applied to P5-P7 slices. In 23 of All data are expressed as means { SE. Statistical analysis of 30 cells, PPD was observed only at short ISIs ( Fig. 1C) : percent values were performed with Wilcoxon (paired data) or PPD at 50 ms was 30.2 { 2.9%; PPD at 200 ms was 5.4 { analysis of variance (ANOVA) (unpaired data) tests. Numerical 1.4%. In these cells, CGP35348 had no effect on either the values were compared with the paired student t-test. Data were amplitude of the eIPCSs nor on PPD. In the presence of 0.5 judged to differ when P õ 0.05. In the paired-pulse protocol, PPD mM CGP35348, PPD at 50 ms was 29 { 3.8% (P Å 0.893 was defined as (eIPSC 1 0 eIPSC 2 )/eIPSC 1 . Cells were considered compared with control, n Å 6) and PPD at 200 ms was to demonstrate PPD if the amplitude of eIPSC 2 was reduced to at least 85% of eIPSC 1 amplitude at 200 ms ISI.
4.8 { 1.8% (P Å 0.345 compared with control, n Å 6). In the seven remaining cells, we observed a significant PPD at 200 ms ISI (22 { 1.6%) that was unaffected by CGP35348 Drugs (0.5 mM, n Å 2). Taken together these results show the absence of GABA B receptor-dependent PPD at all ISIs tested Drugs were dissolved in ACSF and bath applied to the slices and the absence of GABA B receptor-independent PPD at through a three-way tap system. Drugs used in this study included 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX, Tocris, Paris), ISIs longer than 100 ms in the CA3 region of the neonatal D (0)2-amino-5-phosphovaleric acid (D-AP5, Tocris), Baclofen rat hippocampus.
(Sigma), P-3-aminopropyl-P-diethoxymethyl phosphoric acid (CGP35348, Novartis, Basel), and Tiagabine (Novo Nordisk A/
Baclofen reduces eIPSCs in neonates and adults with the
S, Bagsvard, Denmark).
same efficacy
Given that presynaptic GABA B receptor complexes are R E S U L T S present and functional at birth , the The present study is based on intracellular and patch-absence of neonatal GABA B receptor-dependent PPD obclamp recordings of neonatal ( P5 -P7 ) and adult ( P27 -served in this study may be explained by inefficient coupling P34 ) CA3 pyramidal neurons. In the intracellular re-of GABA B receptors with their channels, the presence of a cording configuration neonatal cells had higher input resis-distinct type of GABA B receptor possessing a relatively tances than adult cells ( 105.0 { 6.8 MV at P5 -P7, n Å lower affinity for GABA or simply a smaller amount of 21; and 72.9 { 10.4 MV, n Å 9 at P27 -P34 ) and similar GABA accessing these receptors. To determine whether abresting membrane potentials ( 055.2 { 1.9 mV at P5-P7, sence of PPD in neonates may be due to a lower efficacy n Å 15 and 058.1 { 3.1 mV at P25-P35, n Å 9). In the of presynaptic GABA B receptors, a dose-response curve of presence of CNQX ( 10 mM ) and D-AP5 ( 50 mM ) , electri-the effects of baclofen on eIPSC amplitude was constructed cal stimulation in the hilus evoked a pure monosynaptic (Fig. 2) . In both adults and neonates, bath application of GABA A receptor-mediated postsynaptic current ( eIPSC ) baclofen reversibly reduced the amplitude of eIPSCs in a in cells recorded with QX314-filled electrodes ( QX314 dose dependent manner (Fig. 2, A and B) , without any effect blocks postsynaptic GABA B receptor-mediated potassium on postsynaptic membrane resistance or holding current. currents ) . The maximum amplitude of eIPSCs evoked EC 50 of baclofen, determined by sigmoidal fitting, was from holding potentials of 065 to 075 mV was 01,021 { 0.59 { 0.81 mM and 0.83 { 0.18 mM in adults and neonates, 251 pA (n Å 9 ) and 01,150 { 550 pA (n Å 26 ) for adults respectively. At concentrations that approached the EC 50 and neonates, respectively ( P Å 0.61 ) .
(0.3 and 1 mM) baclofen reduced the amplitude of eIPSCs in neonates and adults to the same extent: 0.3 mM baclofen reduced eIPSC amplitudes to 83.0 { 5.5% and 76.5 { 2.3% Absence of PPD in the neonatal rat hippocampus of control in neonates and adults, respectively (P Å 0.34, n Å 3); 1 mM baclofen reduced eIPSC amplitudes to 63.8 { In adults, when a pair of stimuli with an interstimulus 6.0% and 65.1 { 6.8% of control in neonates and adults, interval (ISI) between 50 and 1,500 ms was delivered at the respectively (P Å 0.55, n Å 3). same intensity, the amplitude of the second eIPSC (eIPSC2)
These results therefore show that absence of GABA B rewas smaller than the first one (Fig. 1A) . This paired-pulse ceptor-dependent PPD in neonates cannot be attributed to a depression (PPD) (Davies et al. 1990 ) was observed in 82% lower efficacy of presynaptic GABA B receptors but rather of the cells tested (14/17). PPD was 33.2 { 3.2% at 200
is likely related to a smaller amount of GABA reaching ms ISI and 12.7 { 4.3% at 1,500 ms ISI (Fig. 1B) . The presynaptic GABA B receptors. effect of the GABA B receptor antagonist CGP35348 was tested on seven of these cells. CGP35348 (0.5 mM) had no effect on the amplitude of the first eIPSC but clearly reduced An increase in release probability reveals PPD in PPD at short ISIs (PPD was 18.2 { 2.6% at 200 ms ISI, neonates P Å 0.028 compared with control, n Å 7). CGP35348 had no effect on PPD at longer ISIs (PPD was 11.0 { 3% at Activation of presynaptic GABA B receptors requires that the initial amount of GABA released by electrical stimula-1,500 ms ISI, P Å 0.71 compared with control, n Å 7) (Fig.  1B) . Thus as already reported (Lambert and Wilson 1994) , tion is high enough to overcome clearance mechanisms that reduce concentration of neurotransmitter in the vicinity of in the adult hippocampal CA3 region, PPD has two components: a GABA B receptor-dependent component that occurs these receptors. Short-term changes associated with pairedpulse paradigms have been shown to be dependent on the with ISIs õ500 ms and peaks at 100-200 ms and a GABA B (Fig. 4A ). As shown in Fig. 4B , although the duration of eIPSCs increased with membrane depolarization, the level of PPD remained constant suggesting that postsynaptic desensitization was not involved. Another factor underlying the PPD may be a change in the driving force for chloride FIG control conditions, 5 min after bath application of baclofen (3 mM) and 15 min after washout of baclofen in a P28 neuron held at 050 mV. B: averaged eIPSC 1 was evoked at membrane holding potentials ranging (n Å 5) traces representing eIPSCs in control conditions, 5 min after bath from 0130 to / 30 mV. After this, in the same cell, eIPSC 1 application of baclofen (3 mM), and 15 min after washout of baclofen in was evoked from a fixed membrane potential (070 mV) and a P5 neuron held at 055 mV. C: grouped data (mean { SE) representing eIPSC 2 from a different membrane potential attained 50 ms % of control eIPSC amplitude vs. concentration of baclofen (0.1-10 mM) in neonatal and adult neurons. before the second stimulation. The reversal potential, determined by linear fitting, was 02 { 3.5 mV for eIPSC 1 and 00.6 { 1.1 mV for eIPSC 2 (P Å 0.73, n Å 3) (Fig. 4C) .
These results indicate that the PPD observed under condiinitial probability of release. Lowering the probability of tions favoring a high probability of neurotransmitter release release favors facilitation, whereas increasing the probability was not due to postsynaptic modifications of GABA B recepof release favors depression (Mallart and Martin 1968) .
tor efficacy but rather involves presynaptic mechanisms. These conditions have been reported to affect both GABA B receptor-dependent and -independent PPD in the adult hippocampus Wilson Blocking the GABA uptake in neonates does not reveal 1994). To test whether or not the absence of PPD was due PPD to an insufficient amount of released GABA, we investigated the effects of an increase in the probability of transmitter The above observations confirm that presynaptic GABA B receptors are present and functional in neonates. They also release in neonates.
In neonates, in the presence of CNQX (10 mM) and D-suggest that a lower amount of GABA released by electrical stimulation underlies the absence of PPD in neonates, but AP5 (50 mM), raising external Ca 2/ concentration from 2 to 4 mM and lowering external Mg 2/ concentration from do not rule out the involvement of a powerful GABA uptake. We therefore studied the effects of tiagabine, a specific 1.3 to 0.3 mM enhanced eIPSC 1 amplitude to 154 { 24% of control (P Å 0.027, n Å 6, Fig. 3A) . In 63% of the cells blocker of GABA uptake (Roepstorff and Lambert 1992) on PPD and half-amplitude duration (t 1/2 ) of eIPSCs. tested (17/27), PPD was revealed. PPD was 27 { 2.7% at 200 ms ISI and 4.0 { 3.4% at 1,500 ms ISI (P Å 0.008 and In adults t 1/2 was 34.0 { 6.0 ms for eIPSC 1 and 20.7 { 2.8 ms for eIPSC 2 , at a holding potential of 070 mV and 0.46, respectively, when compared with control). Application of CGP35348 (0.5 mM) reduced PPD to 14.8 { 2.8% 200 ms ISI; PPD was 29.8 { 11.9% (n Å 5). After a 10-min application of tiagabine (20 mM), t 1/2 of eIPSC 1 and at 200 ms ISI (P Å 0.012, n Å 8) but had no effect at 1,500 ms ISI (7.6 { 4.3%, P Å 0.715, n Å 3) (Fig. 3) 5A ) with no change in holding current (data not shown). 7.5%, P Å 0.463; n Å 6) (Fig. 5, A-C) .
Thus, in the presence of the GABA uptake antagonist PPD also increased significantly to 59.2 { 8.7% (P Å 0.043 compared with control, n Å 5) (Fig. 5A) . Subsequent appli-tiagabine, the kinetics of eIPSCs were slowed in neonates but to a lesser extent than in adults. In addition, no GABA B cation of CGP35348 (0.5 mM) significantly increased t 1/2 of eIPSC 1 and eIPSC 2 by 134.5 { 2.2% and 255.6 { 54.2%, receptor-dependent PPD was revealed, indicating that the absence of this form of PPD in neonates was not the result respectively (eIPSC 1 : 89.5 { 19.6 ms, P Å 0.043; eIPSC 2 : 57.2 { 9.8 ms, P Å 0.043; n Å 5) and slightly enhanced of a powerful GABA uptake. spontaneous activity (data not shown). CGP35348 also significantly decreased PPD to 19.2 { 3.7% (P Å 0.043 com-D I S C U S S I O N pared with control, n Å 5) (Fig. 5, A-C) . These results show that GABA uptake mechanisms shape eIPSCs and reThe present study shows that although presynaptic GABA B receptors located on GABAergic terminals impingduce access to presynaptic GABA B receptors in adult hippocampal CA3 region.
ing CA3 pyramidal neurons of neonates are present and have similar responses to exogenous applied baclofen, they cannot In neonates t 1/2 was 36.6 { 3.9 ms for eIPSC 1 and 31.9 { 2.6 ms for eIPSC 2 at a holding potential of 070 mV be activated by endogenous GABA released following monosynaptic eIPSCs in basal conditions. However, increasand 200 ms ISI; PPD was 9.0 { 2.7% (n Å 10). After a 10-min application of tiagabine (20 mM), t 1/2 of eIPSC 1 and ing probability of GABA release reveals a GABA B receptordependent PPD, thus indicating that, in neonates, the critical eIPSC 2 increased significantly by 135.7 { 9.8% and 122.8 { 5.3%, respectively (eIPSC 1 : 46.9 { 4.0 ms, P Å 0.005; concentration of GABA required for activation of presynaptic GABA B receptors is not achieved with evoked monosyneIPSC 2 : 37.6 { 2.3 ms, P Å 0.007; n Å 10), with no change in holding current (data not shown). PPD increased signifi-aptic GABAergic release.
PPD (Davies et al. 1990 ) has two components. One comcantly to 16.7 { 3.6% (P Å 0.005 compared with control, n Å 7) (Fig. 5, B and C) . Subsequent application of ponent is mediated by the activation of presynaptic GABA B receptors and has been termed GABA B receptor-dependent CGP35348 significantly increased t 1/2 of eIPSC 2 by 119 { 6.5% (44.9 { 5.3 ms, P Å 0.046; n Å 6) but t 1/2 of PPD (Davies et al. 1990; Lambert and Wilson 1994 ) and a J593-7 / 9k26$$mr02 02-06-98 09:01:29 neupa LP-Neurophys tion, in the hippocampus, GABAergic terminals on dendrites exhibit a higher sensitivity to the GABA B receptor agonist baclofen (Lambert and Wilson 1993; Pearce et al. 1995) . However, in our conditions, baclofen depresses evoked monosynaptic GABAergic transmission with the same efficacy in neonates and adults. Finally, we have shown that increasing GABA release probability reveals a GABA B receptor-dependent PPD in neonates. This PPD is likely mediated through presynaptic mechanisms because the magnitude of the PPD was unaffected by membrane holding potential, thus ruling out postsynaptic voltage-dependent desensitization or a change in the chloride driving force. Together these observations demonstrate that the presynaptic mechanisms of inhibition are present and functional on GABAergic terminals in early postnatal life. The absence of GABA B receptor-dependent PPD in CA3 region of neonates is therefore compatible with the idea that synaptically released GABA does not reach the critical concentration required for presynaptic GABA B receptor activation. Possible explanations include reduced release and/ or faster clearance of GABA after electrical stimulation.
Functional synergism between synapses resulting from lateral diffusion of transmitter has been described in Mauthner cells (Faber and Korn 1988) and in the hippocam- FIG . 4. PPD obtained with increased transmitter release probability is independent of membrane potential and is not the result of a change in pus (Isaacson and Nicoll 1993) . Such spill over of GABA eIPSC reversal potential. A: averaged (n Å 5) traces representing pairs of to neighboring presynaptic GABA B receptors may also play eIPSCs delivered at 250 ms ISI at holding potentials of 0110, 070, 050, a crucial role in PPD (Mody et al. 1994) . Indeed, GABA B 030, 010, 10, and 30 mV in a P7 neuron. B: grouped data (mean { SE) receptor-dependent PPD depends on the stimulus intensity representing % of PPD vs. membrane potential. C: same neuron as in A.
Averaged (n Å 5) traces representing pairs of eIPSC delivered at a 250 (Davies et al. 1990; Roepstorff and Lambert 1994) , cannot ms ISI. First eIPSC was delivered at a potential of 070 mV. Second eIPSC be observed with pair-recordings of connected cells (Wilcox was delivered at a holding potential of 0130, 0110, 090, 070, 050, 030, and Dichter 1994) , and is enhanced with GABA uptake 010, 10, and 30 mV attained 50 ms before stimulation. D: grouped data blockers (Roepstorff and Lambert 1994) . Therefore, if the (mean { SE) representing I-V curve for eIPSC 1 (ᮀ) normalized to 10 nS recruited active zones are sparse, or if clearance mechanisms in each experiments and eIPSC 2 reevaluated to keep same ratio with initial IPSC conductance (q) and obtained after protocol presented in C. For are more efficient, such synergism will not occur in neonates. averaging I-V curves, IPSC conductance of eIPSC 1 was determined by As a consequence, the critical concentration of GABA will linear fitting for each experiment and then normalized to 10 nS. eIPSC 2 not be reached in the vicinity of presynaptic GABA B recepwas then reevaluated to maintain ratio with initial IPSC conductance.
tors.
With regard to the first hypothesis, morphological studies second component that does not depend on the activation have shown that in neonates GAD-positive terminals are less of these receptors and has been termed GABA B receptor-numerous, smaller, and contain less vesicles than in adults independent PPD (Lambert and Wilson 1994) . Even though (Seress et al. 1989) . In the present study, we have shown PPD is present in adults at ISIs ranging from 5 ms to 5 s that GABA B receptor-dependent PPD could be revealed by (Davies et al. 1990; Lambert and Wilson 1994) , we show increasing probability of GABA release. Although supportthat in neonates PPD was restricted to ISIs shorter than 200 ing the idea that monosynaptic GABA release is not suffims. This PPD was not GABA B receptor-dependent because cient to activate presynaptic GABA B receptors, this observaapplication of CGP35348 had no effect on the amplitude of tion does not exclude that a faster clearance may prevent the second evoked IPSC.
the access of released GABA to these receptors. However, There are at least two hypotheses that may account for although GABA uptake has been reported to peak above the absence of GABA B receptor-dependent PPD in neonatal adult levels during the two first postnatal weeks of life CA3 pyramidal neurons. One hypothesis is related to the (Coyle and Enna 1976; Wong and McGeer 1981), we could presynaptic GABA B receptor complex (i.e., the absence of not reveal GABA B receptor-dependent PPD in neonates in the receptors or the presence of a distinct subtype of recep-the presence of the GABA uptake antagonist tiagabine. Thus tors), whereas a second hypothesis suggests that the critical GABA uptake does not account for the absence of PPD. concentration of GABA required for the activation of presyn-In addition, as reported in the dentate gyrus (Draguhn and aptic GABA B receptors is not achieved.
Heinemann 1996), GABA uptake does not play a major role in shaping eIPSC kinetics in the CA3 region of neonates. A Support for the first hypothesis is lent by recent findings indicating that in the adult CA3 region presynaptic regulation dilution of GABA in a larger extracellular space in immature tissue could explain the absence of both tiagabine effects of GABA release is heterogeneous; GABA B -resistant GABAergic synapses are located on pyramidal cell body and PPD. Lehmenkühler et al. (1993) reported that the extracellular volume decreases as brain maturation progresses and GABA B -sensitive GABAergic synapses are located on pyramidal dendrites (Lambert and Wilson 1993) . In addi-with strong reductions occurring around postnatal day 10.
J593-7 / 9k26$$mr02 02-06-98 09:01:29 neupa LP-Neurophys FIG . 5. Tiagabine slightly affects eIPSC kinetics but does not reveal GABA B receptor-dependent PPD in neonates. A: averaged (n Å 5) traces representing pairs of eIPSC delivered at 200 ms ISI at a holding potential of 060 mV in a P28 neuron in control, after 10 min exposure of tiagabine (20 mM) and after a 3-min application of CGP35348 (0.5 mM) in presence of tiagabine (20 mM). Tiagabine prolongs kinetics of both eIPSCs and augments degree of PPD. Application of CGP35348 (0.5 mM) reverses PPD and prolongs kinetics of eIPSCs. B: averaged (n Å 5) traces representing pairs of eIPSC delivered at 200 ms ISI at a holding potential of 060 mV in a P5 neuron in control, after 10 min exposure of tiagabine (20 mM) and after a 3-min application of CGP35348 (0.5 mM) in presence of tiagabine (20 mM). Tiagabine prolongs kinetics of both eIPSCs and augments degree of PPD. Application of CGP35348 (0.5 mM) does not reverse PPD but prolongs kinetics of eIPSCs. C: effects of application of tiagabine (20 mM; gray bar) and CGP35348 (0.5 mM; black bar) on amplitude of eIPSC 1 (e1), eIPSC 2 (e2), e2/e1 ratio, t 1/2 eIPSC 1 (t1 1/2 ), t 1/2 , eIPSC 2 (t2 1/2 ) and t2 1/2 /t1 1/2 ratio in a P28 (left) and in a P5 neuron (right). In both cases tiagabine increases t 1/2 eIPSCs but, only in P28 neuron are eIPSC 2 amplitude and t 1/2 increased by application of CGP35348 (0.5 mM).
In addition, in neonatal granule cells, restriction of the extra-shows that single electrical stimulation of the GABAergic fibers is not sufficient to activate presynaptic GABA B recepcellular space prolongs eIPSCs, supporting the idea that in control conditions transmitter is rapidly eliminated from the tors in neonates. Emergence of a GABA B receptor-dependent PPD can be seen only in conditions where the probability synaptic cleft (Draguhn and Heinemann 1996) . Thus the absence of PPD that we observed in neonates may be ac-of GABA release is increased. counted for by a lower amount and/or a critical dilution of We thank Dr. R. Khazipov for critical reading of the manuscript. We released GABA. also thank Dr. H. R. Olpe for the gift of CGP35348 and Dr. I. Danborg for the gift of tiagabine.
Given the important role of GABA B receptors in the con- 
